4

4 Filing

Company: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Filed: January 12, 2017
Period of Report: January 11, 2017
Accession Number: 0001493152-17-000411

View Document ↗ View on SEC.gov ↗